These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 39290977)

  • 1. Optimization of bacteriophage therapy for difficult-to-treat musculoskeletal infections: a bench-to-bedside perspective.
    Bessems L; Chen B; Uyttebroek S; Devolder D; Lood C; Verwimp S; De Munter P; Debaveye Y; Depypere M; Spriet I; Van Gerven L; Dupont L; Wagemans J; van Noort V; Lavigne R; Metsemakers WJ; Onsea J
    Front Cell Infect Microbiol; 2024; 14():1434397. PubMed ID: 39290977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophage Application for Difficult-to-treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment Protocol.
    Onsea J; Soentjens P; Djebara S; Merabishvili M; Depypere M; Spriet I; De Munter P; Debaveye Y; Nijs S; Vanderschot P; Wagemans J; Pirnay JP; Lavigne R; Metsemakers WJ
    Viruses; 2019 Sep; 11(10):. PubMed ID: 31548497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (
    Onsea J; Uyttebroek S; Chen B; Wagemans J; Lood C; Van Gerven L; Spriet I; Devolder D; Debaveye Y; Depypere M; Dupont L; De Munter P; Peetermans WE; van Noort V; Merabishvili M; Pirnay JP; Lavigne R; Metsemakers WJ
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophages and bacterial extracellular vesicles, threat or opportunity?
    Meidaninikjeh S; Mohammadi P; Elikaei A
    Life Sci; 2024 Aug; 350():122749. PubMed ID: 38821215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards Inhaled Phage Therapy in Western Europe.
    Wienhold SM; Lienau J; Witzenrath M
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30909579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
    Dąbrowska K; Abedon ST
    Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacteriophages in the battle against multidrug resistant bacteria].
    van der Meer JWM; Vandenbroucke-Grauls CMJE
    Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage Therapy: Going Temperate?
    Monteiro R; Pires DP; Costa AR; Azeredo J
    Trends Microbiol; 2019 Apr; 27(4):368-378. PubMed ID: 30466900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Back to the future: bacteriophages as promising therapeutic tools.
    Domingo-Calap P; Georgel P; Bahram S
    HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of clinical trials for phage therapy.
    Uchechukwu CF; Shonekan A
    J Med Microbiol; 2024 Sep; 73(9):. PubMed ID: 39320361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.
    Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA
    J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of magistral phage preparations before therapeutic application in patients with chronic rhinosinusitis, sepsis, pulmonary, and musculoskeletal infections.
    Uyttebroek S; Bessems L; Metsemakers W-J; Debaveye Y; Van Gerven L; Dupont L; Depypere M; Wagemans J; Lavigne R; Merabishvili M; Pirnay J-P; Devolder D; Spriet I; Onsea J
    Microbiol Spectr; 2023 Dec; 11(6):e0290723. PubMed ID: 37819122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multiwell-Plate Caenorhabditis elegans Assay for Assessing the Therapeutic Potential of Bacteriophages against Clinical Pathogens.
    Manohar P; Loh B; Elangovan N; Loganathan A; Nachimuthu R; Leptihn S
    Microbiol Spectr; 2022 Feb; 10(1):e0139321. PubMed ID: 35171008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage-mediated modulation of microbiota for diseases treatment.
    Zhang Y; Li CX; Zhang XZ
    Adv Drug Deliv Rev; 2021 Sep; 176():113856. PubMed ID: 34237403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple solid media assay for detection of synergy between bacteriophages and antibiotics.
    Khong E; Oh JJ; Jimenez JM; Liu R; Dunham S; Monsibais A; Rhoads A; Ghatbale P; Garcia A; Cobián Güemes AG; Blanc AN; Chiu M; Kuo P; Proost M; Kline A; Aslam S; Schooley RT; Whiteson K; Fraley SI; Pride DT
    Microbiol Spectr; 2024 May; 12(5):e0322123. PubMed ID: 38526142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.
    Kakasis A; Panitsa G
    Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combatting intracellular pathogens using bacteriophage delivery.
    Goswami A; Sharma PR; Agarwal R
    Crit Rev Microbiol; 2021 Aug; 47(4):461-478. PubMed ID: 33818246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.